These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26306290)

  • 21. Bleeding time prolongation with streptokinase and its reduction with 1-desamino-8-D-arginine vasopressin.
    Johnstone MT; Andrews T; Ware JA; Rudd MA; George D; Weinstein M; Loscalzo J
    Circulation; 1990 Dec; 82(6):2142-51. PubMed ID: 2242538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial.
    Rao AK; Ghosh S; Sun L; Yang X; Disa J; Pickens P; Polansky M
    Thromb Haemost; 1995 Oct; 74(4):1071-8. PubMed ID: 8560416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease.
    Casonato A; Pontara E; Dannhaeuser D; Bertomoro A; Sartori MT; Zerbinati P; Girolami A
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):959-64. PubMed ID: 7893933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease.
    Castaman G; Lattuada A; Mannucci PM; Rodeghiero F
    Br J Haematol; 1995 Jan; 89(1):147-51. PubMed ID: 7833254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of desmopressin on von Willebrand factor multimers in Doberman Pinschers with type 1 von Willebrand disease.
    Callan MB; Giger U; Catalfamo JL
    Am J Vet Res; 2005 May; 66(5):861-7. PubMed ID: 15938072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of DDAVP desmopressin reduces the incidence of microhematomas after facioplasty.
    Palaia DA; Rosenberg MH; Bonanno PC
    Ann Plast Surg; 2001 May; 46(5):463-6. PubMed ID: 11352416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimeric analysis of von Willebrand factor before and after desmopressin acetate (DDAVP) administration intravenously and subcutaneously in male beagle dogs.
    Kraus KH; Turrentine MA; Johnson GS
    Am J Vet Res; 1987 Sep; 48(9):1376-9. PubMed ID: 3499101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of desmopressin acetate administration on primary hemostasis in Doberman Pinschers with type-1 von Willebrand disease as assessed by a point-of-care instrument.
    Callan MB; Giger U
    Am J Vet Res; 2002 Dec; 63(12):1700-6. PubMed ID: 12492285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
    Yang X; Disa J; Rao AK
    Thromb Res; 1990 Sep; 59(5):809-18. PubMed ID: 2237837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet aggregation and pseudothrombocytopenia induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease patient.
    Casonato A; Fabris F; Girolami A
    Eur J Haematol; 1990 Jul; 45(1):36-42. PubMed ID: 2116314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease.
    Sharthkumar A; Greist A; Di Paola J; Winay J; Roberson C; Heiman M; Herbert S; Parameswaran R; Shapiro A
    Haemophilia; 2008 May; 14(3):539-48. PubMed ID: 18312368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of desmopressin in open-heart surgery.
    Cattaneo M
    Haemophilia; 2008 Jan; 14 Suppl 1():40-7. PubMed ID: 18173693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to desmopressin in type IID von Willebrand's disease.
    Thomas N; O'Callaghan U; Lowe GD; Olszynski V; Kernoff PB; Abildgaard CF; Tuddenham EG
    Clin Lab Haematol; 1989; 11(3):189-97. PubMed ID: 2591151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice.
    Garona J; Pifano M; Scursoni AM; Gomez DE; Alonso DF; Ripoll GV
    Anticancer Res; 2014 Sep; 34(9):4761-5. PubMed ID: 25202055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.
    Rose EH; Aledort LM
    Ann Intern Med; 1991 Apr; 114(7):563-8. PubMed ID: 1900403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.
    Leissinger C; Becton D; Cornell C; Cox Gill J
    Haemophilia; 2001 May; 7(3):258-66. PubMed ID: 11380629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.
    Mason JA; Robertson JD; McCosker J; Williams BA; Brown SA
    Haemophilia; 2016 Sep; 22(5):700-5. PubMed ID: 27385253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desmopressin (DDAVP) in bleeding disorders of childhood.
    Sutor AH
    Semin Thromb Hemost; 1998; 24(6):555-66. PubMed ID: 10066151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.